JO
RSLS

John Overdeck’s ReShape Lifesciences Inc. Common Stock RSLS Stock Holding History

John Overdeck’s Portfolio RSLS Stock Details RSLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-568
Closed -$4K – 3778
2018
Q3 		$4K Buy
+568
New +$48.9K ﹤0.01% 3120

Other funds holding RSLS

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

John Overdeck's RSLS Position: Q4 2018 in Review

John Overdeck sold out of ReShape Lifesciences Inc. Common Stock (RSLS) in Q4 2018, closing a stake of 568 shares — an estimated $4K sold.

John Overdeck first reported a position in RSLS in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 2 funds tracked by Wall St. Rank hold RSLS as of Q4 2018.

  • John Overdeck reported no remaining ReShape Lifesciences Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • John Overdeck sold 568 ReShape Lifesciences Inc. Common Stock shares in Q4 2018, an estimated $4K.
  • John Overdeck first reported a position in ReShape Lifesciences Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • John Overdeck's ReShape Lifesciences Inc. Common Stock position peaked at $4K in Q3 2018.
  • 2 funds tracked by Wall St. Rank held ReShape Lifesciences Inc. Common Stock as of Q4 2018.

Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.